Review of a new bone tumor therapy strategy based on bifunctional biomaterials

J Liao, R Han, Y Wu, Z Qian - Bone research, 2021 - nature.com
Bone tumors, especially those in osteosarcoma, usually occur in adolescents. The standard
clinical treatment includes chemotherapy, surgical therapy, and radiation therapy …

Osteosarcoma: cells‐of‐origin, cancer stem cells, and targeted therapies

A Abarrategi, J Tornin, L Martinez-Cruzado… - Stem cells …, 2016 - Wiley Online Library
Osteosarcoma (OS) is the most common type of primary solid tumor that develops in bone.
Although standard chemotherapy has significantly improved long‐term survival over the past …

Bone microenvironment signals in osteosarcoma development

A Alfranca, L Martinez-Cruzado, J Tornin… - Cellular and Molecular …, 2015 - Springer
The bone is a complex connective tissue composed of many different cell types such as
osteoblasts, osteoclasts, chondrocytes, mesenchymal stem/progenitor cells, hematopoietic …

A DNA hypermethylation module for the stem/progenitor cell signature of cancer

H Easwaran, SE Johnstone, L Van Neste… - Genome …, 2012 - genome.cshlp.org
Many DNA-hypermethylated cancer genes are occupied by the Polycomb (PcG) repressor
complex in embryonic stem cells (ESCs). Their prevalence in the full spectrum of cancers …

Progress of phototherapy applications in the treatment of bone cancer

J Sun, F Xing, J Braun, F Traub, PM Rommens… - International journal of …, 2021 - mdpi.com
Bone cancer including primary bone cancer and metastatic bone cancer, remains a
challenge claiming millions of lives and affecting the life quality of survivors. Conventional …

STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma

B Tu, L Du, QM Fan, Z Tang, TT Tang - Cancer letters, 2012 - Elsevier
We previously demonstrated that human mesenchymal stem cells (MSCs) promote the
growth of osteosarcoma in the bone microenvironment. The aim of the present study was to …

New insights about the Wnt/β-catenin signaling pathway in primary bone tumors and their microenvironment: a promising target to develop therapeutic strategies?

G Danieau, S Morice, F Rédini, F Verrecchia… - International journal of …, 2019 - mdpi.com
Osteosarcoma and Ewing sarcoma are the most common malignant primary bone tumors
mainly occurring in children, adolescents and young adults. Current standard therapy …

[HTML][HTML] Advances in osteosarcoma stem cell research and opportunities for novel therapeutic targets

GN Yan, YF Lv, QN Guo - Cancer letters, 2016 - Elsevier
Osteosarcoma is the most common type of bone cancer, especially in children and young
adults. The primary treatment for osteosarcoma is a combination of surgery and …

Salinomycin inhibits osteosarcoma by targeting its tumor stem cells

QL Tang, ZQ Zhao, J Li, Y Liang, JQ Yin, CY Zou… - Cancer letters, 2011 - Elsevier
Osteosarcoma is the most common primary bone tumor in children and adolescents and is
typically associated with a poor prognosis. Tumor stem cells (TSCs) are presumed to drive …

TSSC3 promotes autophagy via inactivating the Src-mediated PI3K/Akt/mTOR pathway to suppress tumorigenesis and metastasis in osteosarcoma, and predicts a …

G Zhao, Z Gao, Q Zhang, X Tang, Y Lv, Z Zhang… - Journal of Experimental …, 2018 - Springer
Background Over the last two or three decades, the pace of development of treatments for
osteosarcoma tends has been slow. Novel effective therapies for osteosarcoma are still …